Guaiacol

Guaiacol (CAS No.: 90-05-1) is a phenolic natural product originally isolated from guaiac resin and formed during lignin oxidation and pyrolysis, classifying it as a bioactive small molecule widely encountered in plant-derived materials and wood smoke. Historically recognized for disinfectant and expectorant properties, guaiacol has gained relevance in biomedical research due to its modulatory effects on inflammatory signaling pathways, including inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression and suppression of NF-κB activation, supporting its characterization as an anti-inflammatory agent with activity typically observed in the low micromolar range in cell-based systems. In addition to its pharmacological profile, guaiacol serves as a well-established reducing co-substrate for peroxidase enzymes, including the peroxidase activity associated with cyclooxygenases, where its oxidation generates chromogenic products that enable sensitive colorimetric quantification of hydroperoxidase activity in biochemical assays. Its dual utility as both a functional probe in enzyme kinetics and a modulator of inflammatory pathways makes it a valuable tool in drug discovery, particularly for screening compounds targeting oxidative and inflammatory processes. Guaiacol has also been detected as a metabolite in certain pathological conditions, such as neuroblastoma and pheochromocytoma, further supporting its relevance in metabolic and disease-related studies, while experimental concentrations and dosing regimens are typically adjusted according to specific in vitro or in vivo research designs.